Chelsea Falls as FDA Rejects Northera; Promethera Gets $31.4M - Mar. 29, 2012

Having trouble viewing this email? View in Browser.

Thursday, March 29, 2012  |   |   |   |  Scottish Development International: The home of whisky and the bionic hand, we're the toast of the scientific community. Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project. Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness. Life Science Map Spotlights Leading Life Science Companies The 2012-2013 Bio NC™ Hotbed Campaign officially launched this morning on BiosSpace.com. Celebrating its 10th year, the Bio NC™ Hotbed highlights leading bioscience and pharmaceutical firms in the Research Triangle Park and across North Carolina. Click here to find the 2012-2013 Bio NC Hotbed homepage. Click here to find the 2012-2013 Bio NC campaign map.   •  Chelsea Therapeutics, Inc. (CHTP) Falls as FDA Rejects Northera More... •  Promethera Gets $31.4 Million More... •  Cancer Research Technology, EIF Create $80 Million Cancer Research Technology Pioneer Fund More... •  Optimer Pharmaceuticals, Inc. (OPTR), Astellas Pharma Inc. (YPH.BE) Ink Pact Worth Up to $110 Million to Commercialize Fidaxomicin for Clostridium Difficile Infection in Japan More... •  Spaulding Clinical Research May Add 183 Jobs Over Two Years More... •  Eli Lilly and Company (LLY)'s Ixekizumab Met Primary Endpoint in Phase II Study in Patients With Plaque Psoriasis More... •  FDA Extends Review of Forest Laboratories, Inc. (FRX) Lung Drug; Action Now Seen in July More... •  Teva Canada Limited (TEVA) to Sell Quebec Plant and Transfer 150 Staff to US CMO More... More Top News Your goals. Our expertise. Norwich Clinical Services is a global contract research organization for the pharmaceutical and biotech industries. Dedicated Norwich program management will guide your program from the initial stages of development through study-end reconciliation with specific focus on budget efficiency and schedule adherence. Please click here for more information. •  In Cancer Science, Many "Discoveries" Don't Hold Up, Amgen (AMGN) Researcher Reveals More... •  Even a Little Drinking May Raise Breast Cancer Risk, University of Heidelberg Study More... •  Can Antibiotics Make You Fat? New York University Reveals More... •  Vitamin D-Fortified Yogurt Drink May Lower Risk of Heart Disease in Type 2 Diabetics, Shahid Beheshti University of Medical Sciences Study More... •  Coffee, Other Stimulant Drugs May Cause High Achievers to Slack Off, University of British Columbia Study More... •  Antipsychotic Drugs Might Raise Heart Attack Risk, Universite Bordeaux Segalen Study More... •  Early Dose of Glucose Thwarts Cardiac Arrest, Tufts Medical Center Study More... •  Complicated Link Between Diet Drinks, Health; University of North Carolina Study More...   More Featured News BUSINESS FOR SCIENTISTS is designed to introduce scientists to business concepts and industry specific tools and frameworks. Basic knowledge in accounting, strategy, finance, and management will be covered and its relevance applied to the biomedical sector. The course will enable you to think of how innovation moves from bench to market. DATES April 16-20, 2012 Fee: $4,850 Please click here for more information. Advances in the Discovery of Biomarkers for Alzheimer's Disease • Gain insight into the current thinking in AD research with regard to the temporal association of biomarkers with disease progression. •Compare the opportunities provided by different biological fluids, including CSF, blood, saliva, and urine as sources of biomarkers in AD. • Assess advances in the use of imaging technologies, including MRI and PET as diagnostic and prognostic tools. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! • Genetown (Boston, Massachusetts) Takeda Pharmaceuticals Director/Sr. Director, Regional Search & Evaluation Responsible for working closely with other relevant functions within the broader Takeda organization to (i) develop a BD strategy consistent with the core therapeutic area R&D and commercial strategies outside of oncology and vaccines (ii) identify and triage opportunities consistent with the agreed strategies and (iii) lead cross-functional due diligence teams to efficiently assess and prioritize in-licensing and alliance opportunities across the R&D pipeline. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Manager / Associate Director, Regulatory Strategy Plans/manage/executes all regulatory activities of all levels of complexity for project of responsibility in development and/or supports regulatory activities for assigned marketed product of responsibility. • Genetown (Woburn, Massachusetts) EMD Millipore Research Scientist III Will develop, transfer, and validate analytical methods to support Upstream Processing development projects such as chemically defined mammalian cell culture media. As such, the candidate will be expected to provide analytical leadership on project teams within the matrix organization and coordinate all analytical activities in support of product development. • Pharm Country (Parsippany, New Jersey) Watson Pharmaceuticals, Inc. Department Coordinator II Maintains regulatory affairs objectives complementary to corporate policies and goals. Request documents and formats data from other departments in a comprehensive package as directed by supervisor for inclusion in submission. Supports maintenance of regulatory affairs information databases to track various statuses of projects. review. • Biotech Beach (La Jolla, California) Pfizer, Inc. Technical Associate/Specialist Participate in routine handling, feeding, transportation, and care of laboratory animals including daily washing, cage change, cleaning, and transportation of animal cages. Ensure that normal housekeeping duties are performed and cleanliness is maintained in the animal work area. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, La Jolla, CA April 17, 2012 • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Merck Frosst Canada Ltd. MaRS Centre - Suite 250 101 College Street Toronto, Ontario M5G 1L7 Canada Merck Frosst Canada Ltd. is a research-driven pharmaceutical company discovering, developing, and marketing a broad range of innovative medicines to improve human health. The Company boasts a long record of innovation and its scientific discoveries have led to medicines alleviating suffering, and prolonging and enhancing the lives of Canadians and people around the world. More Company Profiles FREE Subscription to Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication. Now in its 27th year, GEN retains its position as the most widely read biotechnology publication around the globe. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.